UBS Group’s Cryo-Cell International CCEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $519 | Sell |
100
-1,396
| -93% | -$7.25K | ﹤0.01% | 8479 |
|
|
2025
Q1 | $9.53K | Sell |
1,496
-1,652
| -52% | -$10.5K | ﹤0.01% | 7373 |
|
|
2024
Q4 | $23.3K | Buy |
3,148
+2,899
| +1,164% | +$21.5K | ﹤0.01% | 6547 |
|
|
2024
Q3 | $1.59K | Buy |
+249
| New | +$1.59K | ﹤0.01% | 7384 |
|
|
2024
Q1 | – | Sell |
-741
| Closed | -$4.26K | – | 8159 |
|
|
2023
Q4 | $4.26K | Buy |
+741
| New | +$4.26K | ﹤0.01% | 6678 |
|
|
2023
Q2 | – | Sell |
-177
| Closed | -$535 | – | 7859 |
|
|
2023
Q1 | $535 | Sell |
177
-1,547
| -90% | -$4.68K | ﹤0.01% | 7881 |
|
|
2022
Q4 | $7.29K | Buy |
1,724
+1,587
| +1,158% | +$6.71K | ﹤0.01% | 7720 |
|
|
2022
Q3 | $1K | Sell |
137
-132
| -49% | -$964 | ﹤0.01% | 8824 |
|
|
2022
Q2 | $2K | Sell |
269
-1,160
| -81% | -$8.63K | ﹤0.01% | 8471 |
|
|
2022
Q1 | $11K | Buy |
1,429
+1,425
| +35,625% | +$11K | ﹤0.01% | 7234 |
|
|
2021
Q4 | $0 | Sell |
4
-148
| -97% | – | ﹤0.01% | 9119 |
|
|
2021
Q3 | $2K | Buy |
+152
| New | +$2K | ﹤0.01% | 7777 |
|